The last 15 years have seen a dramatic increase in both the volume and quality of economic evaluations of health care interventions (Elixhauser et al., 1998; Sassi et al., 2002). The demand for evidence on the cost-effectiveness of such interventions has grown, with many countries now having formal or semiformal mechanisms, such as the National Institute for Health and Clinical Excellence (NICE) in England and Wales or the Scottish Medicines Consortium, to feed such information into the policymaking process in the UK.
No takes yet. Share an insight, caveat, or question.
McDaid et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: